Prof. Dr. Nasreen Sultana is honoured to Join Oncidium Foundation as Ambassador of Bangladesh

  Prof. Dr. Nasreen Sultana a leading advocate for advanced cancer care, recently has been appointed Ambassador for Bangladesh by the Oncidium Foundation, a non-profit organisation working to promote equitable access to Targeted Radionuclide Therapy (TRT) for cancer patients worldwide. Prof. Dr.Nasreen Sultana working at NINMAS as head of scintigraphy Division under Bangladesh atomic energy Commission. The Oncidium Foundation works through a global network of ambassadors to raise awareness, support patients and healthcare professionals, and help expand access to theranostics in regions where these innovative treatments remain limited. Expressing gratitude for the appointment, Prof. Dr. Nasreen Sultana said, “I am...

৪৮

Prof. Dr. Nasreen Sultana a leading advocate for advanced cancer care, recently has been appointed Ambassador for Bangladesh by the Oncidium Foundation, a non-profit organisation working to promote equitable access to Targeted Radionuclide Therapy (TRT) for cancer patients worldwide. Prof. Dr.Nasreen Sultana working at NINMAS as head of scintigraphy Division under Bangladesh atomic energy Commission. The Oncidium Foundation works through a global network of ambassadors to raise awareness, support patients and healthcare professionals, and help expand access to theranostics in regions where these innovative treatments remain limited.
Expressing gratitude for the appointment, Prof. Dr. Nasreen Sultana said, “I am delighted and humbled to represent Bangladesh in this important mission. Theranostics holds great promise for our patients, and I look forward to working with colleagues at home and abroad to make these life-changing treatments a reality in Bangladesh.” Theranostics is an emerging approach to cancer care that combines diagnostic imaging with targeted treatment. It enables physicians to identify cancer cells and deliver therapy directly to them, offering the potential for more personalised and effective treatment while reducing damage to healthy tissue.The appointment is expected to strengthen efforts to increase awareness of targeted radionuclide therapy and encourage collaboration among medical professionals, institutions and policymakers in Bangladesh. Prof. Dr. Nasreen Sultana also expressed sincere thanks to the Oncidium Foundation for its trust and congratulated fellow newly appointed ambassadors Dr Pham Phuong of Vietnam and a representative from Egypt. The initiative reflects a growing international effort to ensure that patients, regardless of where they live, can benefit from advances in cancer diagnosis and treatment. “Together, towards cancer care for everyone, everywhere,” Prof. Dr. Nasreen Sultana said.